Folic acid supplements during pregnancy and risk of miscarriage
The LancetPublished 1 September 2001
Jacqueline Gindler, Zhu Li, R. J. Berry, Jun-chi Zheng, Adolfo Correa, Xia-mei Sun
Citations108
SJR quartileQ1
SJR score12.11
SNIP22.72
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
No evidence is found that daily consumption of 400 microg of folic acid before and during early pregnancy influenced a woman's risk for miscarriage, and the distributions of gestational age at pregnancy diagnosis and at miscarriage were similar for both groups of women.
Abstract
In this population-based study of a cohort of women whose use of folic acid supplements while pregnant had been previously documented and who had been pregnant for the first time, we found no evidence that daily consumption of 400 microg of folic acid before and during early pregnancy influenced their risk for miscarriage.
Keywords
Medicine
New England Journal of MedicinePrevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin Supplementation
3,209 Citations1992Andrew E. Czeizel, István Dudás
New England Journal of MedicineIncidence of Early Loss of Pregnancy
2,317 Citations1988Allen J. Wilcox, Clarice R. Weinberg +6 more
New England Journal of MedicinePrevention of Neural-Tube Defects with Folic Acid in China
1,286 Citations1999R. J. Berry, Zhu Li +12 more
Evaluated the outcomes of pregnancy in women who were asked to take a pill containing 400 μg of folic acid alone daily from the time of their premarital examination until the end of their first trimester of pregnancy, and identified 102 and 173 women with neural-tube defects.
The LancetMutated methylenetetrahydrofolate reductase as a risk factor for spina bifida
867 Citations1995Nathalie M.J. van der Put, F. Trijbels +8 more
The mutation was associated with decreased MTHFR activity, low plasma folate, and high plasma homocysteine and red-cell folate concentrations and should be regarded as a genetic risk factor for spina bifida.
American Journal of Obstetrics and GynecologyTherapeutic Abortions with a Folic Acid Antagonist, 4-Aminopteroylglutamic Acid (4-Amino P. G. A.) Administered by the Oral Route
407 Citations1952J. B. Thiersch
The study shows that usage of the drug to induce abortions should in the absence of reliable pregnancy tests be limited to patients in whom surgical intervention is possible to avoid malformations.
PlacentaFolic Acid and Homocyst(e)ine Metabolic Defects and the Risk of Placental Abruption, Pre-eclampsia and Spontaneous Pregnancy Loss: A Systematic Review
405 Citations1999Joel G. Ray, Carl A. Laskin
A systematic literature review to quantify the risk of placental disease in the presence of vitamin B12, folate, homocyst(e)ine or methylenetetrahydrofolate reductase and some pooled data were associated with significant statistical heterogeneity, however.
American Journal of Medical GeneticsGenetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects
294 Citations1999Benedicte Christensen, Laura Arbour +9 more
It is proposed that the genetic-nutrient interaction--MTHFR polymorphism and low folate status--is associated with a greater risk for NTDs than either variable alone.
New England Journal of MedicineFolic Acid and the Prevention of Neural-Tube Defects
271 Citations2004Nicholas Wald
The evidence is conclusive; prevention is effective for women who have not had a pregnancy in which the fetus had a neural tube defect as well as for those who have, and national authorities have recommended that women planning a pregnancy should increase their intake of folic acid.
American Journal of Medical Genetics5,10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects
227 Citations1996C Y Ou, Roger E. Stevenson +7 more
Preliminary data suggest that the 677C-->T polymorphism of the MTHFR gene is a risk factor for spina bifida and anencephaly that may provide a partial biologic explanation for why folic acid prevents these types of NTD.
Public Health Reports (1896-1970)Probabilities of Fetal Mortality
209 Citations1962Fern E. French, Jessie M. Bierman
The estimated probabilities of fetal mortality reported in this paper and the discussion of problems of obtaining and analyzing data on fetal losses in early pregnancy are based on a followup study of pregnancies on the island of Kauai during the 4-year period 1953-56, which uses a broad epidemiologic approach.
Marcel Dekker eBooksMicronutrients in health and in disease prevention
129 Citations1991Adrianne Bendich, Charles E. Butterworth
The current and recent research on the link between dietary micronutrients and critical health issues, such as cancer, cardiovascular disease, arthritis, immunity, birth defects, cataracts, and other acute and chronic illnesses, is summarized.
The LancetCan terathanasia explain the protective effect of folic-acid supplementation on birth defects?
87 Citations1997Ernest B. Hook, Andrew E. Czeizel
It is found that the only randomised occurrence study of folic-acid supplementation found a statistically significant association not only with diminished prevalence of birth defect, but also with an increased prevalence of recognised spontaneous abortion.
Clinical GeneticsExploring gene—gene interactions in the etiology of neural tube defects
49 Citations1998Lorenzo D. Botto, Pierpaolo Mastroiacovo
Though the original study was too small to detect statistically significant differences among most of the risk estimates, the results suggest that gene‐gene interaction may play a role in modulating the susceptibility to NTDs in a proportion of affected individuals.
The LancetFolic acid and prevention of neural-tube defects
34 Citations1997Caroline Hurren, Lucy Thorpe +3 more
Non-pregnant women and women in intermediateto high-risk categories for neural tube defects, such as a previous neural tube defect– affected pregnancy, should take 4 to 5 mg of folic acid daily.
The LancetTrouble-shooting in minimally invasive direct coronary artery bypass
25 Citations1997Mohammad Bashar Izzat, Anthony P.C. Yim
The LancetFolic acid and prevention of neural-tube defects
19 Citations1997Nicholas Wald, Allan Hackshaw